Search Results - "ZHU, Chang Z"
-
1
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Published in The Journal of pharmacology and experimental therapeutics (01-12-2006)“…ATP-sensitive P2X(7) receptors are localized on cells of immunological origin including glial cells in the central nervous system. Activation of P2X(7)…”
Get more information
Journal Article -
2
Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity
Published in Journal of medicinal chemistry (14-01-2010)“…Several 3-acylindoles with high affinity for the CB2 cannabinoid receptor and selectivity over the CB1 receptor have been prepared. A variety of 3-acyl…”
Get full text
Journal Article -
3
Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
Published in British journal of pharmacology (01-01-2011)“…BACKGROUND AND PURPOSE Cannabinoid CB2 receptor activation by selective agonists has been shown to produce analgesic effects in preclinical models of…”
Get full text
Journal Article -
4
A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat
Published in Proceedings of the National Academy of Sciences - PNAS (24-12-2002)“…P2X 3 and P2X 2/3 receptors are highly localized on peripheral and central processes of sensory afferent nerves, and activation of these channels contributes…”
Get full text
Journal Article -
5
Short-term oral gavage administration of adenine induces a model of fibrotic kidney disease in rats
Published in Journal of pharmacological and toxicological methods (01-11-2018)“…The adenine model of kidney disease typically involves dietary delivery of adenine over several weeks. This model can be variable in its disease progression…”
Get full text
Journal Article -
6
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats
Published in The Journal of pharmacology and experimental therapeutics (01-07-2005)“…The vanilloid receptor 1 (VR1, TRPV1), which is a member of the transient receptor potential (TRP) superfamily, is highly localized on peripheral and central…”
Get more information
Journal Article -
7
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Published in The Journal of pharmacology and experimental therapeutics (01-01-2009)“…Studies demonstrating the antihyperalgesic and antiallodynic effects of cannabinoid CB(2) receptor activation have been largely derived from the use of…”
Get more information
Journal Article -
8
Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia
Published in Journal of neurosurgery (01-10-2004)“…Insulin has been shown to ameliorate cerebral necrosis in global and, more recently, in focal cerebral ischemia. The goal of this study was to determine the…”
Get full text
Journal Article -
9
Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities
Published in European journal of pharmacology (15-12-2004)“…Preclinical data, performed in a limited number of pain models, suggest that functional blockade of metabotropic glutamate (mGlu) receptors may be beneficial…”
Get full text
Journal Article -
10
Role of central and peripheral mGluR5 receptors in post-operative pain in rats
Published in Pain (Amsterdam) (01-03-2005)“…Metabotropic glutamate receptors (mGluRs) have previously been shown to play a role in pain transmission during inflammatory or neuropathic pain states…”
Get full text
Journal Article -
11
Analgesic activity of metabotropic glutamate receptor 1 antagonists on spontaneous post-operative pain in rats
Published in European journal of pharmacology (12-02-2008)“…Activation of metabotropic glutamate (mGlu) receptors has previously been shown to play a role in inflammatory or neuropathic pain states. However, the role of…”
Get full text
Journal Article -
12
Differential action potentials and firing patterns in injured and uninjured small dorsal root ganglion neurons after nerve injury
Published in Brain research (29-05-2004)“…The profile of tetrodotoxin sensitive (TTX-S) and resistant (TTX-R) Na + channels and their contribution to action potentials and firing patterns were studied…”
Get full text
Journal Article -
13
Targeting Anti-TGF- β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach
Published in Journal of the American Society of Nephrology (01-12-2017)“…Targeted delivery of a therapeutic agent to a site of pathology to ameliorate disease while limiting exposure at undesired tissues is an aspirational treatment…”
Get full text
Journal Article -
14
Central and peripheral sites of action for CB 2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
Published in British journal of pharmacology (01-01-2011)“…BACKGROUND AND PURPOSE Cannabinoid CB 2 receptor activation by selective agonists has been shown to produce analgesic effects in preclinical models of…”
Get full text
Journal Article -
15
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain
Published in Bioorganic & medicinal chemistry (15-06-2008)“… The synthesis and pharmacological characterization of a novel furan-based class of voltage-gated sodium channel blockers is reported. Compounds were…”
Get full text
Journal Article -
16
Effects of A‐317491, a novel and selective P2X 3 /P2X 2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration
Published in British journal of pharmacology (02-02-2009)“…We have recently reported that systemic delivery of A‐317491, the first non‐nucleotide antagonist that has high affinity and selectivity for blocking P2X 3…”
Get full text
Journal Article -
17
Dissociation between post-surgical pain behaviors and spinal Fos-like immunoreactivity in the rat
Published in European journal of pharmacology (15-02-2006)“…Previous studies have demonstrated that Fos-like immunoreactivity is increased in spinal dorsal horn neurons in several pain models, and have suggested that…”
Get full text
Journal Article -
18
Potentiation of analgesic efficacy but not side effects: Co-administration of an alpha 4 beta 2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats
Published in Biochemical pharmacology (15-10-2011)“…Positive modulation of the neuronal nicotinic acetylcholine receptor (nAChR) alpha 4 beta 2 subtype by selective positive allosteric modulator NS-9283 has…”
Get full text
Journal Article -
19
A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury
Published in European journal of pharmacology (05-10-2016)“…Adenosine (ADO) is an important regulatory purine nucleoside that accumulates at sites of inflammation and tissue injury including in diseases associated with…”
Get full text
Journal Article -
20
Potentiation of analgesic efficacy but not side effects: Co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats
Published in Biochemical pharmacology (15-10-2011)“…Positive allosteric modulator NS-9283 enhances NNR α4β2 agonist ABT-594 (up to 100 nmol/kg)-induced analgesic efficacy in animal models of pain, and cortical…”
Get full text
Journal Article Conference Proceeding